Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient

NCT02958059 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT02958059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02958059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2016
Completion date
August 31, 2020
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign biliary stricture, bile duct cancer resectable, biliary obstructive disease such as choledocholithiasis, klatskin tumor, peri-ampullary cancer